Biosample Core The overarching mission of the GI SPORE Biosample Core is to collect, catalogue and distribute human biological samples with associated pertinent clinical data to the projects to facilitate translation research and help them accomplish their specific aims. The Biosample Core will be housed and administered within the Department of Pathology to ensure uncompromised patient care and confidentiality. The explicit goals of the Biosample Core include: (1) Uncompromised pathology diagnosis and patient care. Tissues will collected with informed consent imder IRB-approved protocols and patient confidentiality will be protected. (2) Prospective procurement and processing of colonic and pancreatic tissues from resection specimens. The Biosample Core with work closely with and enhance the existing Tissue Procurement Service to obtain highquality tissue samples not needed for diagnosis. (3) Prospective collection of blood and serum from patients with colorectal and pancreatic cancer, both pre-operative and post-operative. (4) Expert pathology review of colonic and pancreatic tissues. Internationally recognized colonic and pancreatic patiiologists will review all collected tissues and assist with selection of tissues for tissue array construction and interpretation of immunohistochemically-stained slides. (4) Data management. Pertinent pathologic and clinical information will be collected and managed in conjunction with GI SPORE Biostatistics and Bioinformatics Core and the Bioinformatics Group at Dartmouth Medical College. (5) Tissue array construction for validation studies. In conjunction with the UMCCC Tissue Core, the Biosample Core will construct colonic and pancreatic tissue arrays from archival pathology material. (6) Assist in tissue-based gene expression and biomarker validation studies, such as immunohistochemistry and automated in situ protein detection. Collectively, the many services of the GI SPORE Biosample Core will facilitate translational research and enhance the resources of other NCI-supported networks and groups.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
5P50CA130810-05
Application #
8729832
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2014-09-01
Budget End
2015-08-31
Support Year
5
Fiscal Year
2014
Total Cost
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Type
DUNS #
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Cuneo, Kyle C; Mehta, Ranjit K; Kurapati, Himabindu et al. (2018) Enhancing the Radiation Response in KRAS Mutant Colorectal Cancers Using the c-Met Inhibitor Crizotinib. Transl Oncol 12:209-216
Cooper, Gregory S; Markowitz, Sanford D; Chen, Zhengyi et al. (2018) Evaluation of Patients with an Apparent False Positive Stool DNA Test: The Role of Repeat Stool DNA Testing. Dig Dis Sci 63:1449-1453
Mills, Jason C; Samuelson, Linda C (2018) Past Questions and Current Understanding About Gastric Cancer. Gastroenterology 155:939-944
Dame, Michael K; Attili, Durga; McClintock, Shannon D et al. (2018) Identification, isolation and characterization of human LGR5-positive colon adenoma cells. Development 145:
Ulintz, Peter J; Greenson, Joel K; Wu, Rong et al. (2018) Lymph Node Metastases in Colon Cancer Are Polyclonal. Clin Cancer Res 24:2214-2224
Wilson, Matthew J; Sen, Ananda; Bridges, Dave et al. (2018) Higher baseline expression of the PTGS2 gene and greater decreases in total colonic fatty acid content predict greater decreases in colonic prostaglandin-E2 concentrations after dietary supplementation with ?-3 fatty acids. Prostaglandins Leukot Essent Fatty Acids 139:14-19
Stoffel, Elena M; Koeppe, Erika; Everett, Jessica et al. (2018) Germline Genetic Features of Young Individuals With Colorectal Cancer. Gastroenterology 154:897-905.e1
Parsels, Leslie A; Karnak, David; Parsels, Joshua D et al. (2018) PARP1 Trapping and DNA Replication Stress Enhance Radiosensitization with Combined WEE1 and PARP Inhibitors. Mol Cancer Res 16:222-232
Maust, Joel D; Frankowski-McGregor, Christy L; Bankhead 3rd, Armand et al. (2018) Cyclooxygenase-2 Influences Response to Cotargeting of MEK and CDK4/6 in a Subpopulation of Pancreatic Cancers. Mol Cancer Ther 17:2495-2506
Rho, Jung-Hyun; Ladd, Jon J; Li, Christopher I et al. (2018) Protein and glycomic plasma markers for early detection of adenoma and colon cancer. Gut 67:473-484

Showing the most recent 10 out of 103 publications